AI platform for discovering and developing RNA-based therapies for genetic conditions.

Tool: Deep Genomics AI Platform
Description: AI platform for discovering and developing RNA-based therapies for genetic conditions.
Summary: Deep Genomics uses artificial intelligence to simplify the complexity of RNA biology, aiming to accelerate the discovery and development of RNA-based therapies for genetic conditions. Their AI Platform identifies novel targets and evaluates thousands of therapeutic candidates, focusing on precision and efficiency in drug development. The platform supports the exploration of RNA splicing defects and the creation of therapies for a wide range of genetic diseases.
Category: Drug Discovery
Tags: Predictive Analytics, Precision Medicine, Drug Discovery
Use Cases: Identifying novel RNA targets for rare genetic diseases.; Evaluating therapeutic candidates for genetic conditions at scale.
Platform: Web
Vendor: Deep Genomics
Target Users: Researcher
Pricing: not for sale
Regulatory: not a medical device
Meta: Deep Genomics AI Platform accelerates RNA-based therapy discovery and development for genetic conditions using advanced AI.
Content: [Company](https://www.deepgenomics.com/company/) [AI Platform](https://www.deepgenomics.com/AI-Platform/) [News](https://www.deepgenomics.com/news/) [Careers](https://www.deepgenomics.com/careers/) [Contact](https://www.deepgenomics.com/contact/) - [Company](https://www.deepgenomics.com/company/) - [AI Platform](https://www.deepgenomics.com/AI-Platform/) - [News](https://www.deepgenomics.com/news/) - [Careers](https://www.deepgenomics.com/careers/) - [Contact](https://www.deepgenomics.com/contact/) Programming RNA Therapies Any Gene, Any Genetic condition Revolutions in AI, RNA biology and automation are enabling a new approach to drug development. Deep Genomics is at the forefront. ![](https://www.deepgenomics.com/media/images/icon4.original.png) ## AI-Powered Discovery **The future of drug development will rely on artificial intelligence, because biology is too complex for humans to understand** RNA as a therapeutic modality has arrived on a global scale with new medicines approved for rare disease and as vaccines. This is only the beginning. Everyone will face a genetic condition in their lifetime. And, because RNA therapies can be programmed to precisely target genetic causes, we can conceive of addressing most genetic conditions. Finding therapies requires mining RNA biology data. But, this data is vast, complex and overwhelming, making standard approaches to drug discovery too slow and costly. Deep Genomics has the solution: Our AI Platform untangles the complexity in RNA biology, identifies novel targets, and evaluates thousands of possibilities to identify the best therapeutic candidates. We seek to program therapies for any gene and any genetic condition. [Learn More](https://www.deepgenomics.com/AI-Platform/) ![](https://www.deepgenomics.com/media/images/icon5.original.png) ## AI Drives Unprecedented Number of Valuable Medicines by Combining Prediction and Scale **Our proprietary AI Platform is designed for data-driven prediction, positive feedback loops, and exponential growth.** In 2018, our proprietary AI Platform unlocked our first targets in which RNA splicing was the defect and the mechanism for correction. In 2023 we released the first Foundation Model for RNA Biology, BigRNA. We are currently developing BigRNA+, which will expand the number of mechanisms and genetic variants we can pursue. This includes expanding into more complex genetic diseases and discovering new biology. As genetic targets are less understood in complex genetic disease, the AI Platform will play an even greater role in identifying novel targets, as well as therapies, to modulate disease. [Learn More](https://www.deepgenomics.com/AI-Platform/) ## Join Us We are looking for individuals who are inspired to join us in building a new kind of world-class genetic medicine company. [Learn More](https://www.deepgenomics.com/careers/) ### Find Us Corporate Headquarters: 480 University Avenue, Suite 1300 Toronto, Ontario, Canada, M5G 1V2 Boston Office: 1 Canal Park, S

Deep Genomics AI Platform accelerates RNA-based therapy discovery and development for genetic conditions using advanced AI.

Deep Genomics AI Platform

Deep Genomics uses artificial intelligence to simplify the complexity of RNA biology, aiming to accelerate the discovery and development of RNA-based therapies for genetic conditions. Their AI Platform identifies novel targets and evaluates thousands of therapeutic candidates, focusing on precision and efficiency in drug development. The platform supports the exploration of RNA splicing defects and the creation of therapies for a wide range of genetic diseases.

Deep Genomics AI Platform

Categories

Description

Summary

Use Cases

Platforms

Regulatory Status

API Available

Added to Directory

Target Customer

Contact